Injectable Drug Compatibility News

Spring 2023 In this update we added a new monograph for LACOSAMIDE. We also added new stability information to the monographs for ASCORBIC ACID, CONJUGATED ESTROGENS, LEVOLEUCOVORIN CALCIUM, SODIUM BICARBONATE, and THIAMINE HYDROCHLORIDE. New compatibility information was added to the existing drug monographs for CYTARABINE, DEXAMETHASONE SODIUM PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE SODIUM SUCCINATE, ONDANSETRON HYDROCHLORIDE, and DEXMEDETOMIDINE with twenty-three other drugs.

Winter 2022 In this update we added a new monograph for TOCILIZUMAB. We also added new stability information to the monographs for DIGOXIN, HYDROMORPHONE HYDROCHLORIDE, MORPHINE HYDROCHLORIDE, SODIUM CHLORIDE, and VANCOMYCIN HYDROCHLORIDE. New compatibility information was added to the existing drug monograph for AMPHOTERICIN B, BUMETANIDE, FOSFOMYCIN DISODIUM, PLAZOMICIN, SCOPOLAMINE HYDROBROMIDE, and IMIPENEM, CILASTATIN AND RELEBACTAM with 28 other drugs.

In this update we added a new monograph for MARGETUXIMAB-CMKB and METHYLPHENIDATE HYDROCHLORIDE. We also added new stability information to the monographs for CEFTOLOZANE AND TAZOBACTAM, CEFUROXIME SODIUM, FILGRASTIM, INSULIN ASPART, INSULIN GLULISINE, INSULIN LISPRO, LEVETIRACETAM, PIPERACILLIN AND TAZOBACTAM, and VANCOMYCIN HYDROCHLORIDE. New compatibility information was added to the existing drug monograph for IMIPENEM, CILASTATIN, and RELEBACTAM with 52 other drugs.

In this update we added a new monograph for FOSDENOPTERIN HYDROBROMIDE. We also added new stability information to the monographs for DOBUTAMINE HYDROCHLORIDE, IRON DEXTRAN, and ZICONOTIDE. New compatibility information was added to the existing drug monograph for CEFIDEROCOL SULFATE TOSYLATE with 91 different parenteral drugs.

In this update we added a new monograph for CASIMERSEN. We also added new stability information for for AMPICILLIN SODIUM and INSULIN, REGULAR. New compatibility information was added to these existing drug monographs: MEROPENEM with 101 other drugs, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VORICONAZOLE.